Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Exploring the Latest Advancements in Biotech Consultancy Services

Dec 30, 2025

The biotech industry is rapidly evolving, and consultancy services are playing a pivotal role in driving this innovation. From helping startups to guiding established firms, biotech consultants are at the forefront of technological advancements. In this post, we explore the latest developments in biotech consultancy services and how they are shaping the future of the industry.

Understanding Biotech Consultancy

Biotech consultancy services offer specialized knowledge and expertise to companies operating within the biotechnology sector. These services include strategic planning, regulatory compliance, research and development, and commercialization. Leveraging their expertise, consultants help businesses navigate complex scientific and regulatory landscapes.

One of the major benefits of biotech consultancy is access to cutting-edge technologies and methodologies. Consultants often work with a wide array of clients, allowing them to gather and share insights across various fields. This cross-pollination of ideas is crucial for fostering innovation.

biotech laboratory

Emerging Trends in Biotech Consultancy

The demand for personalized medicine is reshaping the biotech landscape. Consultants are now focusing on strategies that enable companies to develop personalized therapeutic solutions. This includes leveraging genomic data and advanced analytics to tailor treatments to individual patients.

Another trend is the integration of artificial intelligence (AI) and machine learning. These technologies are transforming how data is analyzed and interpreted, offering new insights into complex biological processes. Biotech consultants are helping companies harness these technologies to enhance research and development efforts.

artificial intelligence biotech

Sustainability and Environmental Impact

With increasing awareness of environmental issues, sustainability has become a priority in biotech consultancy. Consultants are advising clients on eco-friendly practices and sustainable product development. This includes reducing waste, optimizing resource use, and minimizing the carbon footprint of biotech operations.

By implementing sustainable practices, biotech firms not only contribute to environmental preservation but also gain competitive advantages. Consumers and investors are increasingly favoring companies that demonstrate a commitment to sustainability.

sustainability biotech

Regulatory Challenges and Solutions

Navigating regulatory requirements is a significant challenge in the biotech industry. Consultants provide essential guidance to ensure compliance with local and international regulations. This includes assistance with clinical trials, product approvals, and market access strategies.

Regulatory expertise is crucial for biotech firms aiming to expand into global markets. Consultants help businesses understand and meet the diverse regulatory standards across different regions, facilitating smoother market entry and growth.

The Future of Biotech Consultancy

The future of biotech consultancy is promising, with ongoing advancements in technology and science. As the industry continues to evolve, consultants will play a critical role in shaping strategies that drive innovation and growth. Their ability to adapt to new trends and challenges will be key to their success.

Overall, biotech consultancy services are indispensable for companies looking to thrive in a competitive and rapidly changing environment. By staying ahead of industry trends and leveraging expert guidance, biotech firms can achieve significant breakthroughs and make a meaningful impact on global healthcare.